USD 8.27
(4.03%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Abbott Laboratories | 6.57 Billion USD | 100.0% |
Allurion Technologies Inc. | 6.17 Million USD | 100.0% |
Artivion, Inc. | 81.97 Million USD | 100.0% |
Avanos Medical, Inc. | 163.2 Million USD | 100.0% |
Butterfly Network, Inc. | 75.83 Million USD | 100.0% |
Butterfly Network, Inc. | 75.83 Million USD | 100.0% |
Bio-Rad Laboratories, Inc. | 780.51 Million USD | 100.0% |
Boston Scientific Corporation | 2.48 Billion USD | 100.0% |
CONMED Corporation | 318.32 Million USD | 100.0% |
Edwards Lifesciences Corporation | 1.16 Billion USD | 100.0% |
Paragon 28, Inc. | 98.06 Million USD | 100.0% |
Glaukos Corporation | 41.98 Million USD | 100.0% |
Globus Medical, Inc. | 848.13 Million USD | 100.0% |
Inspire Medical Systems, Inc. | 33.88 Million USD | 100.0% |
Integer Holdings Corporation | 239.71 Million USD | 100.0% |
Medtronic plc | 5.21 Billion USD | 100.0% |
Myomo, Inc. | 1.8 Million USD | 100.0% |
Nevro Corp. | 118.67 Million USD | 100.0% |
Owlet, Inc. | 6.49 Million USD | 100.0% |
Penumbra, Inc. | 388.02 Million USD | 100.0% |
Smith & Nephew plc | 2.39 Billion USD | 100.0% |
STERIS plc | 674.53 Million USD | 100.0% |
Stryker Corporation | 4.84 Billion USD | 100.0% |
Vapotherm, Inc. | 22.96 Million USD | 100.0% |
Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 100.0% |